WO2019049072A1 - A novel green micro-emulsion for controlling fungal wilt diseases - Google Patents

A novel green micro-emulsion for controlling fungal wilt diseases Download PDF

Info

Publication number
WO2019049072A1
WO2019049072A1 PCT/IB2018/056823 IB2018056823W WO2019049072A1 WO 2019049072 A1 WO2019049072 A1 WO 2019049072A1 IB 2018056823 W IB2018056823 W IB 2018056823W WO 2019049072 A1 WO2019049072 A1 WO 2019049072A1
Authority
WO
WIPO (PCT)
Prior art keywords
oil
cake
microemulsion formulation
microemulsion
formulation
Prior art date
Application number
PCT/IB2018/056823
Other languages
French (fr)
Inventor
Satyawati Sharma
Abhishek Sharma
Saurabh Dubey
S. N. Naik
Original Assignee
Indian Institute Of Technology, Delhi
Secretary, Department Of Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indian Institute Of Technology, Delhi, Secretary, Department Of Biotechnology filed Critical Indian Institute Of Technology, Delhi
Priority to EP18854764.0A priority Critical patent/EP3678641A4/en
Priority to BR112020004685-0A priority patent/BR112020004685A2/en
Priority to US16/645,529 priority patent/US20200281194A1/en
Publication of WO2019049072A1 publication Critical patent/WO2019049072A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/12Asteraceae or Compositae [Aster or Sunflower family], e.g. daisy, pyrethrum, artichoke, lettuce, sunflower, wormwood or tarragon
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/18Euphorbiaceae [Spurge family], e.g. ricinus [castorbean]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/22Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/24Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/26Meliaceae [Chinaberry or Mahogany family], e.g. mahogany, langsat or neem
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/28Myrtaceae [Myrtle family], e.g. teatree or clove
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40Liliopsida [monocotyledons]
    • A01N65/44Poaceae or Gramineae [Grass family], e.g. bamboo, lemon grass or citronella grass
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/40Liliopsida [monocotyledons]
    • A01N65/48Zingiberaceae [Ginger family], e.g. ginger or galangal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/67Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger

Definitions

  • the present invention relates to development of anti-fungal botanical based micro- emulsion formulation that comprises essential oils in dispersed phase and an aqueous plant biomass extract in continuous phase.
  • Fusarium wilt is a fungal disease caused primarily by Fusarium oxysporum and it infects, among others, tomatoes and legume crops. Annual losses of up to 10-15% of the crop damage are associated with Fusarium wilt of tomato.
  • These soil-borne fungi cause vascular wilts by infecting plants through the roots and growing internally through the cortex to the stele. The vascular tissues of the root, and then the stem, are colonized by growth of hyphae and movement of conidia in the transpiration stream. Initial symptoms appear as chlorosis and distortion of the lower leaves, often on one side of the plant.
  • Foliar chlorosis, necrosis, and plant stunting become more pronounced as the disease progresses. Wilting occurs on the affected side of the plant, followed by vascular discoloration and stem necrosis. The entire plant wilts and dies as the pathogen moves into the stem. F. oxysporum, plays the role of a silent assassin - the pathogenic strains of this fungus can be dormant for 30 years before resuming virulence and infecting a plant.
  • the pathogen is primarily spread over short distances by irrigation water and contaminated farm equipment but can also be spread over long distances either in infected transplant or soil.
  • the disease or infection can also be transmitted through infected plant material and through contaminated soil.
  • European Patent (EP 2826372 Al) relates to the use of an essential oil and/or a supercritical extract, both of which are taken from the Artemisia absinthium L plant populations in Teruel and/or the Sierra Nevada, as a fungicide, i.e., to control phytopathogenic fungi in agricultural crops.
  • Bowers and Locke (2000) stated that several commercial formulations of botanical extracts and essential oils were being investigated as possible alternatives to soil fumigation for control of Fusarium wilt diseases.
  • Seoud et al. (2005) discloses the antimicrobial activities (including fungicidal activity against F. oxysporum) of different plant essential oils and a biocide formulation prepared from these essential oils with the aid of emulsifiers.
  • the continuous phase of the nano-emulsion is distilled water and is devoid of any active ingredients.
  • Imael Henri Nestor Bassole et. al.: Molecules 2012, 17, 3989-4006 discloses use of combinations of EOs as a new approach towards increasing the antimicrobial efficacy of EOs in foods, taking advantage of their synergistic and additive effects. The purpose of this review is to provide an overview on the antimicrobial efficacy of these combinations. A survey of the methods used for the determination of the interactions and mechanisms involved in the antimicrobial activities of these combinations are also reported.
  • Nasreen Sultana et. al.: Pak. J. Bot, 45(6): 2149-2156, 2013 discloses fungicides, microbial antagonists and oil cakes that were used in vitro and in vivo to control Fusarium oxysporum, in bottle gourd and cucumber.
  • mustard oil cake amendment in soil significantly controlled the seed borne diseases.
  • Mustard cake supplemented at high ratio reduced seedling mortality caused by F. oxysporum and markedly increased germination in bottle gourd and cucumber.
  • it does not disclose development of a microemulsion formulation comprising aqueous mustard cake in the continuous phase.
  • the present invention provides an antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture of lipophilic bioactive ingredients in dispersed phase; b) 18-57 wt.% of a plant biomass aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of an amphiphilic surfactant.
  • an antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture of two essential oils at a ratio of 1 : 1 in dispersed phase; b) 18-57 wt.% of a plant biomass aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of an amphiphilic surfactant.
  • a fungicidal composition comprising 1394 ppm to 4000 ppm amount of the oil -in-water microemulsion formulation as developed in the present invention, BRIEF DESCRIPTION OF ACCOMPANYING DRAWINGS
  • Figure 1 illustrates the effect of composition D on mycelia growth of wilt fungus, F. oxysporum before and after accelerated storage condition (15 days at 40°C & 70% Relative Humidity (RH).
  • the graph revealed that MIC value for the formulation is 4000 ppm.
  • Microemulsion formulation remained almost stable after 15 days and inhibited 94.5% of fungal growth.
  • Figure 2 illustrates the effect of composition B on mycelia growth of wilt fungus, F. oxysporum before and after accelerated storage condition (15 days at 40°C & 70% RH).
  • the graph revealed that MIC value for the formulation is 6000 ppm.
  • Microemulsion formulation inhibited 83.5% of fungal growth after 15 days suggesting loss of potency after storage.
  • Figure 3 illustrates Fusarium oxysporum spore reduction (%) during time by using minimum inhibition concentrations of composition B and D ( Eq. (2)).
  • the kinetic model revealed 1.33 times faster fungicidal activity of composition D comparing to B.
  • Figure 4 illustrates the effect of Microemulsion formulation at various doses (MIC, IC90 and IC50) and chemical (Carbendazim @0.1%) on disease reduction (%) of FOL
  • the present invention relates to a fungicidal composition
  • a fungicidal composition comprising bioactive ingredients from the plants which are both lipophilic (essential oils) and hydrophilic (plant biomass aqueous extracts) in nature, but residing in different phases of the emulsion.
  • the composition is further characterized in that it is formulated as an oil-in water microemulsion.
  • Microemulsions are homogenous, transparent, and thermodynamically stable dispersions of oil and water stabilized by a surfactant, usually in combination with co-surfactant with a droplet size typically in the range of 10-100 nm.
  • a microemulsion may be in the form of a liquid or a gel, i.e. in liquid or semisolid form.
  • the microemulsion is in liquid form.
  • the preparation of microemulsion usually involves low-energy emulsification method.
  • the lipophilic bioactive ingredients in dispersed phase of the microemulsion are plant essential oils.
  • hydrophobic essential oils or aromatic plant essences
  • EO hydrophobic essential oils
  • plants which mainly include biosynthetically related groups such as terpenes, terpenoids, aromatic and aliphatic constituents.
  • biosynthetically related groups such as terpenes, terpenoids, aromatic and aliphatic constituents.
  • these EOs into water soluble liquid forms (emulsions, micelles etc.), intended to be employed for controlled release of active ingredients and protecting them from the external environment.
  • the use of combinations, either from whole EOs or artificial mixtures of purified main components aims to increase the efficacy of the essential oil by taking advantage of the synergistic and additive properties that these components can exhibit.
  • the lipophilic components in the dispersed phase of the microemulsion are selected on the basis of their synergistic performance against fungal wilt pathogen i.e. F. oxysporum. These components are chosen from a group of essential oils consisting of clove oil, lemon grass oil, mint oil, thyme oil, eucalyptus oil, ginger oil, sesame oil, basil oil, geranium oil, rosemary oil, lavender oil, marigold oil, preferably clove oil and lemongrass oil. Further, in such synergistic mixture, clove oil and lemongrass oil is present in a ratio of 1 : 1.
  • cloves are the aromatic flower buds of a tree in the family Myrtaceae while Cymbopogon, better known as lemongrass, is a genus of Asian, African, Australian, and tropical island plants in the grass family.
  • the chemical analyses carried out show a specific qualitative and quantitative composition of the EOs obtained from these plants.
  • Eugenol 75.41%) is the major compound in clove essential oil while Citral-a (32.80%) and Citral-b (30.35%) ae the most abundant in lemongrass oil.
  • Clove and lemongrass oil in the microemulsion formulation of the current invention is specifically present in 1 : 1 ratio in the dispersed phase.
  • the total content of the mixture of EOs ranges from 2.5-5wt % and more preferably the composition comprises of 5wt% EO mixture.
  • the anti-fungal efficacy studies of the present microemulsion formulation is carried out by analyzing their minimum inhibitory concentration (MIC) against F. oxysporum.
  • MIC minimum inhibitory concentration
  • Such study as conducted in the present invention indicates that clove essential oil is more potent (31.25 ppm) and provides consistent fungicidal effect compared to lemongrass oil (62.5 ppm).
  • the combination of the two has been found to produce a synergistic effect at a ratio of 1 : 1 w/w against fungal wilt pathogen, F. oxysporum.
  • Such synergistic effect not only to enhance their antifungal efficacy, but also makes the preparation of such biopesticide cost effective.
  • the present formulation further comprises an amphiphilic component (surfactants), preferably a combination of two surfactants (Smix).
  • Suitable surfactants can be selected from the group consisting of phospholipids, alkyl polyglucosides, sorbitan esters with fatty acids, polyalkyleneglycol ethers of fatty alcohols (e.g. lauryl-, stearyl-, cetyl-, or palmityl alcohol), and/or pegylated mono- and diesters of glycerol with fatty acids for the development of microemulsion formulation.
  • the preferred Surfactant mixture includes castor oil ethoxylates 40 moles ethylene oxides (CoE-40) and polyoxyethylene sorbitan monolaurate or polysorbate 20 (Tween-20) in the range of 1 : 1, 6:4, 7:3 and 8:2.
  • the amount of Smix in the microemulsion composition ranges 5-20 wt.% which is relatively low surfactant content and in fact, one of the particular benefits of the present invention.
  • the hydrophilic bioactive component used in the continuous phase comprise an antifungal plant biomass aqueous extract chosen from edible oil cakes (for e.g.
  • the said continuous phase may further comprise of distilled water in combination with one or more inert liquid glycols, such as glycerol, propylene glycol, pentylene glycol, and/or polyethylene glycol .
  • Mustard cake extract is prepared by mixing cake and water in 1 :5 (w/v) ratios followed by soaking in water-bath for 2 hours at 100°C. To get cake free extract, the mixture is filtered through muslin cloth and further centrifuged at 10,000 rpm for 15 minutes at 28°C to clarify the solution. The mustard cake extract obtained is considered as 100%. All ingredients are stirred at 750 rpm for 30-60 min to assure a stable and fine dispersion of oil particles in form of a microemulsion. Optionally, ultrasound treatment of the combined ingredients can be used to accelerate the formation of a homogeneous microemulsion.
  • the composition comprises a larger amount of hydrophilic continuous phase, that accounts for around 60-90 wt.% of total formulation, wherein, the aqueous extract of the hydrophilic plant biomass is around 18-57wt% of total formulation or 25-75wt% of continuous phase.
  • O/W microemulsion has distilled water as inert continuous phase.
  • the present inventors have utilized the antifungal mustard cake aqueous extract in continuous phase.
  • Such preparation of the antifungal mustard cake in continuous phase provides two major benefits. Firstly, it increases the shelf life to about 2 years at room temperature while such aqueous botanical extracts known to be highly susceptible to contamination having very short shelf-life (24-48 h).
  • these aqueous extracts though cheaper, are weaker antifungal agents compared to essential oils, but when prepared in continuous phase, it enhances the overall potency of the microemulsion against Fusarium sp. induced wilt disease.
  • An embodiment of the present invention provides an antifungal, oil-in-water microemulsion formulation comprising: a) 2.5-5 wt.% of a synergistic mixture of two lipophilic bioactive ingredients in dispersed phase: b) 18-57 wt.% of an aqueous extract of a hydrophilic bioactive ingredient in the continuous phase of distilled water; and c) 5- 20 wt.% of amphiphilic surfactant.
  • the present antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture clove oil and lemongrass oil at a ratio of 1: 1 in dispersed phase; b) 18-57 wt.% of a mustard cake aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of castor oil ethoxylates 40 moles ethylene oxides and polyoxyethylene sorbitan monolaurate are present in a ratio selected from 1 : 1 , 6.4, 7:3 or 8:2,
  • a microemulsion formulation having 37.5 wt% mustard cake extract and 37.5 wt.% water (i.e. 1: 1 ratio) have a particle size of 54.20 nm, with MIC value 4000 ppm.
  • the microemulsion formulation without mustard cake extract shows less potency against F. oxysporum and inhibits 100% mycelia growth at 6000 ppm.
  • the microemulsion of the present invention may be prepared by any methods well known in the art. Such methods include condensation or low-energy emulsification methods (the system goes through low interfacial tensions during the emulsification process) or by application of high energy input during emulsification, the so-called dispersion methods (A. Forgiarini,J. Esquena, C. Gonza'lez, and C. Solans Langmuir 2001). To test the shelf life of the formulation, two formulations (with and without cake extract) are kept at 40°C at 70% Relative Humidity (RH) and 4°C for 15 days for their accelerated storage stability tests. After 15 days, no separation of phases (oil and water) have been observed, thus indicating shelf life of the formulation to be two years at room temperature.
  • RH Relative Humidity
  • a kinetic model is also developed to better understand the antifungal activity, especially when continuous phase is used as an active in a microemulsion formulation.
  • the results demonstrate that present microemulsion composition comprising mustard cake in continuous phase is capable of killing fungal spores 1.33-7 times faster than those without them.
  • the in vivo experimental studies for evaluating the antifungal efficacies of three concentrations of the current microemulsion formulation (MIC, IC90 and IC50) against - Fusarium sp. germination assay shows that the current ME formulation is non-phytotoxic to tomato seeds at all concentrations with germination % of 91-93%.
  • Another embodiment of the present invention provides a bio-pesticide comprising 1394 ppm to 4000 ppm amount of the oil-in-water microemulsion formulation developed in the present invention.
  • the micro-emulsion formulation of the present invention that essentially comprises two opposite nature ingredients in two different phases of the emulsion i.e. lipophilic bioactive components in the dispersed phase and hydrophilic bioactive component in the continuous phase is advantageously capable of delivering antifungal active ingredients from both dispersed and continuous phases.
  • the currently developed formulation is highly effective even after harsh storage conditions and shows antifungal activity under both in vitro and in vivo conditions.
  • the present invention can be further described by way of non-limiting examples: EXAMPLES:
  • Example 1 illustrates the quantitative effects of EOs used in the present microemulsion formulation comprising a mixture of clove oil and lemongrass oil in the dispersed phase, in terms of FIC (fractional inhibitory concentration) indices.
  • FIC indices are calculated as FICA + FICB, where FICA and FICB are the minimum concentrations that inhibited the bacterial growth for EOs A (clove oil) and B (lemongrass oil), respectively.
  • FICA (MIC combination / MICA alone)
  • FICB (MICB combination / MICB alone).
  • the results are interpreted as synergy (FIC ⁇ 0.5), addition (0.5 ⁇ FIC ⁇ 1), indifference (1 ⁇ FIC ⁇ 4) or antagonism (FIC > 4) (Schelz at el., 2006).
  • Example 2 Preparation of oil-in water microemulsion containing EO mixture (1:1 ratio) in dispersed phase and mustard cake extract in continuous phase
  • Example 2 illustrates the four different microemulsion compositions prepared in accordance with the present invention. These compositions are depicted in tables 2 to 7 below:
  • composition A Composition A
  • Example 3 In vitro Bioefficacy of microemulsion compositions (B and D) against Fusarium oxysporum (Before and after accelerated storage stability test)
  • Example 3 demonstrates the enhanced antifungal efficacy of the present microemulsion formulation by virtue of the presence of hydrophilic mustard cake aqueous extract in the continuous phase.
  • Microemulsions with different ratio of mustard cake extract are prepared and their MIC values against F. oxysporum are determined through poisoned food technique.
  • PDA Potato Dextrose Agar
  • 100 ml is poured into sterilized Petri dishes (90 mm diameter) and measured amount of microemulsion (for e.g. For 4000 ppm- 0.4g in 100 ml; and for 65000 ppm- 0.65 g in 100ml) is added to get the required concentrations.
  • control sets are prepared using equal amounts of blank formulation (without active ingredients) in place of oil.
  • a fungal disc (5 mm in diameter) of F. oxysporum, cut from the periphery of a five day-old culture using a cork borer, is inoculated aseptically into the centre of each Petri dish.
  • the plates are sealed with polyethylene film and incubated at a temperature of 28+2°C until the growth in the control plates reaches the edge of the plates.
  • the plates are used in triplicate for each treatment. Percentage inhibition of the radial growth by different oils compared to control is calculated using below equation:
  • % Inhibition (C-T)/0100 where C is radial growth in control and T is radial growth in different concentrations of microemulsion.
  • composition B without mustard cake extract
  • D with 50% mustard cake extract
  • composition D does not get affected (94.5% inhibition at MIC value of 0 day)
  • composition B comparatively deteriorated in terms of efficacy and only 83.5 % inhibition is observed at its MIC value i.e. 6000 ppm ( Figure 2).
  • Composition 6000 90 98.9 ⁇ 22.1 ⁇ 1.73 6.17 0.98 B 1.28
  • Figure 3 demonstrates F. oxysporum spore reduction (%) during time by using minimum fungicidal concentrations of composition B and composition D (b).
  • the kinetic models thus reveal 1.33 times faster fungicidal activity of composition D compared to composition B, thus justifying the significance of using active in continuous phase of the present microemulsion formulation.
  • Example 4 Preparation of a comparative oil-in water microemulsion containing a single EO in dispersed phase and mustard cake extract in continuous phase
  • Example 4 illustrates a comparative microemulsion wherein the continuous phase comprises of only one oil i.e. clove oil, as depicted in table 9 below:
  • the above formulation is transparent microemulsions formed spontaneously upon mixing. After 15 days at 40°C & 70% RH, this sample of the microemulsions is visually inspected, and no indication of physical instability is found.
  • composition G is found to be 6000 ppm.
  • the MIC value thus obtained for composition G shows lesser efficacy than that of composition D (currently developed composition having MIC at 4000ppm), but is at par with composition B (without bioactive ingredient in continuous phase; MIC at 6000ppm).
  • This loss of efficacy is attributed towards the presence of single/lower amount of EO in composition G which equates to the MIC of composition B that is devoid of any bioactive ingredient in continuous phase.
  • the higher efficacy of current composition D is due to the presence of both these essential features together i.e. a synergistic mixture of two EOs in dispersed phase along with presence of an aqueous extract of a hydrophilic bioactive ingredient in continuous phase.
  • Example 5 Effect of microemulsion (ME) formulation (composition D) on tomato seed germination and incidence of Fusarium wilt in tomato crops
  • Example 5 illustrates the Germination assay conducted on current ME formulation.
  • Tomato seeds (variety PUSA Ruby) are sterilized by 4% sodium hypochlorite solution by keeping the seeds in the solution for 2 minutes and then washed with distilled water 3 times and are soaked in tissue paper.
  • Treatment consists of selected microemulsion (composition D) formulation with different concentrations (MIC, MIC90 and MIC50). Seeds are then dipped in different treatments for 30 min. 2 types of control are taken, positive control (without F. oxysporum, healthy soil) and negative control (with F. oxysporum, unhealthy soil). Experiment is conducted for 8 days and repeated thrice.
  • Seedling Vigor is the sum total of those properties of the seed which determine the level of activity and performance of the seed or seed lot during germination and seedling emergence. It is measured by two formulas given below:
  • results The data reveals that the present microemulsion formulation treatments do not affect the germination of tomato seeds even in the presence of wilt fungus and thus produce a healthy seedling indicated by high seedling vigour index as provided in table 10 below:
  • seeds, seedlings and soil are treated with above mentioned three concentrations of microemulsion formulation.
  • soil is autoclaved and artificially inoculated with Fusarium spores (@ 2.6 x 10 5 spores/g soil). Seeds are treated with microemulsion formulations by the method used for germination study, but herein, seeds are sowed directly into 1 kg diseased pot.
  • seedling treatment healthy eight-leaf staged seedlings of tomato are treated with three respective concentrations of microemulsion while in case of soil treatment; soil of pot is treated @ 5 ml per 150 cc soil. Healthy and untreated seedlings are taken as control.
  • AUDPC Area Under Disease Progression curve
  • AUDPC ⁇ [(Ri+1 + Ri)/2][ti+l - ti],
  • R disease rating at the ith observation
  • n total number of observations.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dispersion Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The present invention relates to an antifungal oil-in water microemulsion formulation comprising two different bioactive ingredients which are lipophilic (essential oils) and hydrophilic (plant biomass aqueous extracts) in nature, but reside in different phases of the said microemulsion. In particular, the present invention provides a liquid microemulsion comprising a synergistic mixture of two essential oils as the active ingredient in the dispersed phase and a hydrophilic biomass aqueous extract in continuous phase that not only facilitates the overall antifungal efficacy of the microemulsion but also maintains its potency against wilt inducing fungus F. oxysporum during storage.

Description

A NOVEL GREEN MICRO-EMULSION FOR CONTROLLING
FUNGAL WILT DISEASES
FIELD OF THE INVENTION The present invention relates to development of anti-fungal botanical based micro- emulsion formulation that comprises essential oils in dispersed phase and an aqueous plant biomass extract in continuous phase.
BACKGROUND OF THE INVENTION Wilt diseases is one of the most widespread and destructive diseases occurring in many major ornamental and horticultural crops. Fusarium wilt is a fungal disease caused primarily by Fusarium oxysporum and it infects, among others, tomatoes and legume crops. Annual losses of up to 10-15% of the crop damage are associated with Fusarium wilt of tomato. These soil-borne fungi cause vascular wilts by infecting plants through the roots and growing internally through the cortex to the stele. The vascular tissues of the root, and then the stem, are colonized by growth of hyphae and movement of conidia in the transpiration stream. Initial symptoms appear as chlorosis and distortion of the lower leaves, often on one side of the plant. Foliar chlorosis, necrosis, and plant stunting become more pronounced as the disease progresses. Wilting occurs on the affected side of the plant, followed by vascular discoloration and stem necrosis. The entire plant wilts and dies as the pathogen moves into the stem. F. oxysporum, plays the role of a silent assassin - the pathogenic strains of this fungus can be dormant for 30 years before resuming virulence and infecting a plant. The pathogen is primarily spread over short distances by irrigation water and contaminated farm equipment but can also be spread over long distances either in infected transplant or soil. The disease or infection can also be transmitted through infected plant material and through contaminated soil. Other means of spreading the disease is through human movement around the infected field, or the use of irrigation water and implements previously used on an infected crop. Currently, diseases which attack horticulture crops are controlled using commercial fungicides (Mancozeb, carbendazim, carboxin etc.). It is obvious that the wide use of agrochemical treatments for pest control leads to some deleterious effects on most of the ecosystems and non-target organisms. Also, long-term extensive fungicides in open field have led to the appearance of fungicide-resistant populations of fungal pathogens. Due to the hazard and toxic effects of agrochemicals, an alternative or natural method should be used in plant protection. Plants produce a number of secondary metabolites which have antimicrobial activity against a wide range of micro-organisms. Therefore, the formulation of these metabolites must be introduced to overcome their degradation and to be used practically during handling and application as biopetsicides.
European Patent (EP 2826372 Al) relates to the use of an essential oil and/or a supercritical extract, both of which are taken from the Artemisia absinthium L plant populations in Teruel and/or the Sierra Nevada, as a fungicide, i.e., to control phytopathogenic fungi in agricultural crops. Bowers and Locke (2000) stated that several commercial formulations of botanical extracts and essential oils were being investigated as possible alternatives to soil fumigation for control of Fusarium wilt diseases. Seoud et al. (2005) discloses the antimicrobial activities (including fungicidal activity against F. oxysporum) of different plant essential oils and a biocide formulation prepared from these essential oils with the aid of emulsifiers. Abd-Elsalam and Khokhlov (2015) reported oil- in-water nanoemulsion of eugenol against F. oxysporum. Bioiumigation by means of Brassicaceae green manure or seed meal incorporation into soil is another promising, environmentally friendly alternative to chemical fumigation by methyl bromide for the control of soil-borne pathogens. This biological approach is based on the release of glucosinolate-derived toxic compounds, mediated by endogenous myrosinase (E.C. 3.2.1.147) from Brassicaceae disrupted tissues or seed meals, in the presence of water (Brown and Morra, 1997).
Although prior arts disclose the development and deployment of plant derived products to target soil borne pathogens, there remain certain drawbacks such as the efficacy of these materials falls short when compared to synthetic pesticides and also require somewhat greater application rates and may require frequent reapplication when used in field. Therefore, in order to harness these green/herbal products to their full potential there are several avenues that have to be explored, primarily the use of combinations of plant products (essential oils, plant extracts etc.).
Abhishek Sharma et. al.: Journal of Bioscience and Bioengineering, 2016 discloses antifungal effects of four essential oils viz., clove (Syzygium aromaticum), lemongrass (Cymbopogon citratus), mint {Mentha piperita) and eucalyptus {Eucalyptus globulus) oils that were evaluated against the wilt causing fungus F. oxysporum. Among all these selected oils, clove oil showed maximum antifungal activity and hence it was selected for the development of oil- in -water nanoemulsion formulation. The stability test conducted revealed the shelf life of formulation to be two years with MIC of 0.4%. However, the continuous phase of the nano-emulsion is distilled water and is devoid of any active ingredients. Imael Henri Nestor Bassole et. al.: Molecules 2012, 17, 3989-4006 discloses use of combinations of EOs as a new approach towards increasing the antimicrobial efficacy of EOs in foods, taking advantage of their synergistic and additive effects. The purpose of this review is to provide an overview on the antimicrobial efficacy of these combinations. A survey of the methods used for the determination of the interactions and mechanisms involved in the antimicrobial activities of these combinations are also reported.
Nasreen Sultana et. al.: Pak. J. Bot, 45(6): 2149-2156, 2013 discloses fungicides, microbial antagonists and oil cakes that were used in vitro and in vivo to control Fusarium oxysporum, in bottle gourd and cucumber. In this study, mustard oil cake amendment in soil significantly controlled the seed borne diseases. Mustard cake supplemented at high ratio reduced seedling mortality caused by F. oxysporum and markedly increased germination in bottle gourd and cucumber. However, it does not disclose development of a microemulsion formulation comprising aqueous mustard cake in the continuous phase.
Therefore, there is still a need in the art to develop a process for preparing an emulsion wherein both lipophilic (essential oils) and hydrophilic (plant biomass aqueous extracts) active ingredients are incorporated together in one o/w formulation but in different phases. OBJECTIVES OF THE INVENTION
It is an objective of the present invention to overcome the drawbacks of the prior arts.
It is another objective of the present invention to develop an oil-in water microemulsion comprising essential oils as active ingredient in dispersed phase and plant biomass aqueous extract as active ingredient in continuous phase.
It is another objective of the present invention to provide a microemulsion comprising a combination of two synergistic essential oils (clove and lemongrass oil) in a defined concentration ratio of 1 : 1 in the dispersed phase.
It is another objective of the present invention to prepare an oil-in-water microemulsion wherein the continuous phase contains an aqueous extract of a bioactive ingredient selected from edible oil cakes, non-edible oil cakes or herbs.
It is yet another objective of the invention to provide an oil-in-water microemulsion comprising two synergistic essential oils in dispersed phase and active aqueous extract of mustard cake in continuous phase that is effective against F. oxysporum in tomato plants. SUMMARY OF THE INVENTION
In one aspect the present invention, it provides an antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture of lipophilic bioactive ingredients in dispersed phase; b) 18-57 wt.% of a plant biomass aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of an amphiphilic surfactant.
In another aspect of the present invention, it provides an antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture of two essential oils at a ratio of 1 : 1 in dispersed phase; b) 18-57 wt.% of a plant biomass aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of an amphiphilic surfactant. In a further aspect of the present invention, it provides a fungicidal composition comprising 1394 ppm to 4000 ppm amount of the oil -in-water microemulsion formulation as developed in the present invention, BRIEF DESCRIPTION OF ACCOMPANYING DRAWINGS
Figure 1 illustrates the effect of composition D on mycelia growth of wilt fungus, F. oxysporum before and after accelerated storage condition (15 days at 40°C & 70% Relative Humidity (RH). The graph revealed that MIC value for the formulation is 4000 ppm. Microemulsion formulation remained almost stable after 15 days and inhibited 94.5% of fungal growth.
Figure 2 illustrates the effect of composition B on mycelia growth of wilt fungus, F. oxysporum before and after accelerated storage condition (15 days at 40°C & 70% RH). The graph revealed that MIC value for the formulation is 6000 ppm. Microemulsion formulation inhibited 83.5% of fungal growth after 15 days suggesting loss of potency after storage.
Figure 3 illustrates Fusarium oxysporum spore reduction (%) during time by using minimum inhibition concentrations of composition B and D ( Eq. (2)). The kinetic model revealed 1.33 times faster fungicidal activity of composition D comparing to B.
Figure 4 illustrates the effect of Microemulsion formulation at various doses (MIC, IC90 and IC50) and chemical (Carbendazim @0.1%) on disease reduction (%) of FOL
DETAILED DESCRIPTION OF INVENTION
The following description with reference to the accompanying drawings is provided to assist in a comprehensive understanding of exemplary embodiments of the invention. It includes various specific details to assist in that understanding but these are to be regarded as merely exemplary. Accordingly, those of ordinary skill in the art will recognize that various changes and modifications of the embodiments described herein can be made without departing from the scope of the invention. In addition, descriptions of well-known functions and constructions are omitted for clarity and conciseness. The terms and words used in the following description and claims are not limited to the bibliographical meanings, but, are merely used by the inventor to enable a clear and consistent understanding of the invention. Accordingly, it should be apparent to those skilled in the art that the following description of exemplary embodiments of the present invention are provided for illustration purpose only and not for the purpose of limiting the invention as defined by the appended claims and their equivalents.
It is to be understood that the singular forms "a," "an," and "the" include plural referents unless the context clearly dictates otherwise.
Features that are described and / or illustrated with respect to one embodiment can be used in the same way or in a similar way in one or more other embodiments and / or in combination with or instead of the features of the other embodiments.
It should be emphasized that the term "comprises / comprising" when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof. The present invention relates to a fungicidal composition comprising bioactive ingredients from the plants which are both lipophilic (essential oils) and hydrophilic (plant biomass aqueous extracts) in nature, but residing in different phases of the emulsion. The composition is further characterized in that it is formulated as an oil-in water microemulsion. Microemulsions are homogenous, transparent, and thermodynamically stable dispersions of oil and water stabilized by a surfactant, usually in combination with co-surfactant with a droplet size typically in the range of 10-100 nm. In terms of its rheological properties, a microemulsion may be in the form of a liquid or a gel, i.e. in liquid or semisolid form. In a preferred embodiment of the present invention, the microemulsion is in liquid form. The preparation of microemulsion usually involves low-energy emulsification method. In the present invention, the lipophilic bioactive ingredients in dispersed phase of the microemulsion are plant essential oils. These hydrophobic essential oils (EO), or aromatic plant essences, are volatile and fragrant substances with an oily consistency especially produced by plants, which mainly include biosynthetically related groups such as terpenes, terpenoids, aromatic and aliphatic constituents. Thus the biological activities of EOs can be lost by volatilization of active components or its degradation by act of high temperatures; oxidation and UV light. These disadvantages make the commercial application of these oils limited. Another major drawback with EOs is their sparing solubility in aqueous phases. Hence, the concentration of these hydrophobic antimicrobials is low in solvent phase where pathogens inhabit. Accordingly, it is required to formulate these EOs into water soluble liquid forms (emulsions, micelles etc.), intended to be employed for controlled release of active ingredients and protecting them from the external environment. Further, the use of combinations, either from whole EOs or artificial mixtures of purified main components aims to increase the efficacy of the essential oil by taking advantage of the synergistic and additive properties that these components can exhibit.
The lipophilic components in the dispersed phase of the microemulsion are selected on the basis of their synergistic performance against fungal wilt pathogen i.e. F. oxysporum. These components are chosen from a group of essential oils consisting of clove oil, lemon grass oil, mint oil, thyme oil, eucalyptus oil, ginger oil, sesame oil, basil oil, geranium oil, rosemary oil, lavender oil, marigold oil, preferably clove oil and lemongrass oil. Further, in such synergistic mixture, clove oil and lemongrass oil is present in a ratio of 1 : 1. As particularly used in the present invention, cloves (Syzygium aromaticum) are the aromatic flower buds of a tree in the family Myrtaceae while Cymbopogon, better known as lemongrass, is a genus of Asian, African, Australian, and tropical island plants in the grass family. The chemical analyses carried out show a specific qualitative and quantitative composition of the EOs obtained from these plants. Eugenol (75.41%) is the major compound in clove essential oil while Citral-a (32.80%) and Citral-b (30.35%) ae the most abundant in lemongrass oil. Clove and lemongrass oil in the microemulsion formulation of the current invention is specifically present in 1 : 1 ratio in the dispersed phase. The total content of the mixture of EOs ranges from 2.5-5wt % and more preferably the composition comprises of 5wt% EO mixture.
The anti-fungal efficacy studies of the present microemulsion formulation is carried out by analyzing their minimum inhibitory concentration (MIC) against F. oxysporum. Such study as conducted in the present invention indicates that clove essential oil is more potent (31.25 ppm) and provides consistent fungicidal effect compared to lemongrass oil (62.5 ppm). However, the combination of the two has been found to produce a synergistic effect at a ratio of 1 : 1 w/w against fungal wilt pathogen, F. oxysporum. Such synergistic effect not only to enhance their antifungal efficacy, but also makes the preparation of such biopesticide cost effective.
The present formulation further comprises an amphiphilic component (surfactants), preferably a combination of two surfactants (Smix). Suitable surfactants can be selected from the group consisting of phospholipids, alkyl polyglucosides, sorbitan esters with fatty acids, polyalkyleneglycol ethers of fatty alcohols (e.g. lauryl-, stearyl-, cetyl-, or palmityl alcohol), and/or pegylated mono- and diesters of glycerol with fatty acids for the development of microemulsion formulation. The preferred Surfactant mixture (Smix) includes castor oil ethoxylates 40 moles ethylene oxides (CoE-40) and polyoxyethylene sorbitan monolaurate or polysorbate 20 (Tween-20) in the range of 1 : 1, 6:4, 7:3 and 8:2. The amount of Smix in the microemulsion composition ranges 5-20 wt.% which is relatively low surfactant content and in fact, one of the particular benefits of the present invention. The hydrophilic bioactive component used in the continuous phase comprise an antifungal plant biomass aqueous extract chosen from edible oil cakes (for e.g. mustard cake, cotton seed cake, groundnut cake, sesame cake, linseed cake, coconut cake, olive cake, sunflower oil cake, palm oil cake), nonedible oil cakes (for e.g. jatropha cake, neem cake, castor cake, karanja cake, simorubha cake, tung cake) and herbs (for e.g. Allium sativum, Piper nigrum, Zingiber officinale. Piper longum, Ocimum sanctum, Curcuma longa, Cinnamomum zeyianicum. Piper longum. The said continuous phase may further comprise of distilled water in combination with one or more inert liquid glycols, such as glycerol, propylene glycol, pentylene glycol, and/or polyethylene glycol .
In a preferred embodiment, the uses mustard cake extract as bioactive ingredient in the continuous phase of the emulsion.
Mustard cake extract is prepared by mixing cake and water in 1 :5 (w/v) ratios followed by soaking in water-bath for 2 hours at 100°C. To get cake free extract, the mixture is filtered through muslin cloth and further centrifuged at 10,000 rpm for 15 minutes at 28°C to clarify the solution. The mustard cake extract obtained is considered as 100%. All ingredients are stirred at 750 rpm for 30-60 min to assure a stable and fine dispersion of oil particles in form of a microemulsion. Optionally, ultrasound treatment of the combined ingredients can be used to accelerate the formation of a homogeneous microemulsion.
In the present invention, the composition comprises a larger amount of hydrophilic continuous phase, that accounts for around 60-90 wt.% of total formulation, wherein, the aqueous extract of the hydrophilic plant biomass is around 18-57wt% of total formulation or 25-75wt% of continuous phase.
Usually, O/W microemulsion has distilled water as inert continuous phase. However, the present inventors have utilized the antifungal mustard cake aqueous extract in continuous phase. Such preparation of the antifungal mustard cake in continuous phase provides two major benefits. Firstly, it increases the shelf life to about 2 years at room temperature while such aqueous botanical extracts known to be highly susceptible to contamination having very short shelf-life (24-48 h). Secondly, these aqueous extracts, though cheaper, are weaker antifungal agents compared to essential oils, but when prepared in continuous phase, it enhances the overall potency of the microemulsion against Fusarium sp. induced wilt disease. The present inventors have thus found that except for one where 100% distilled water is replaced with mustard cake extract, all other formulations having 25-75 wt% of distilled water being replaced by mustard cake extract are more stable, effective and having a particle size of 20-100 ran. An embodiment of the present invention provides an antifungal, oil-in-water microemulsion formulation comprising: a) 2.5-5 wt.% of a synergistic mixture of two lipophilic bioactive ingredients in dispersed phase: b) 18-57 wt.% of an aqueous extract of a hydrophilic bioactive ingredient in the continuous phase of distilled water; and c) 5- 20 wt.% of amphiphilic surfactant.
In another embodiment, the present antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture clove oil and lemongrass oil at a ratio of 1: 1 in dispersed phase; b) 18-57 wt.% of a mustard cake aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of castor oil ethoxylates 40 moles ethylene oxides and polyoxyethylene sorbitan monolaurate are present in a ratio selected from 1 : 1 , 6.4, 7:3 or 8:2,
In a preferred embodiment of the present invention, a microemulsion formulation has been provided having 37.5 wt% mustard cake extract and 37.5 wt.% water (i.e. 1: 1 ratio) have a particle size of 54.20 nm, with MIC value 4000 ppm. The microemulsion formulation without mustard cake extract shows less potency against F. oxysporum and inhibits 100% mycelia growth at 6000 ppm.
The microemulsion of the present invention may be prepared by any methods well known in the art. Such methods include condensation or low-energy emulsification methods (the system goes through low interfacial tensions during the emulsification process) or by application of high energy input during emulsification, the so-called dispersion methods (A. Forgiarini,J. Esquena, C. Gonza'lez, and C. Solans Langmuir 2001). To test the shelf life of the formulation, two formulations (with and without cake extract) are kept at 40°C at 70% Relative Humidity (RH) and 4°C for 15 days for their accelerated storage stability tests. After 15 days, no separation of phases (oil and water) have been observed, thus indicating shelf life of the formulation to be two years at room temperature.
The antifungal efficacy of both the formulations before and after storage has been determined. It is observed that the efficacy of microemulsion with cake extract in continuous phase remain almost intact (94.5% inhibition at 4000 ppm i.e. MIC value of 0 day), whereas, the microemulsion with water as continuous phase deteriorates in terms of efficacy and is capable of only 83.5 % inhibition at 6000 ppm compared to 100% on 0 day. The use of mustard cake extract in the continuous phase of the formulation thus not only enhances the overall efficacy of the formulation, but also results in enhancing the shelf life.
A kinetic model is also developed to better understand the antifungal activity, especially when continuous phase is used as an active in a microemulsion formulation. The results demonstrate that present microemulsion composition comprising mustard cake in continuous phase is capable of killing fungal spores 1.33-7 times faster than those without them.
Further, the in vivo experimental studies for evaluating the antifungal efficacies of three concentrations of the current microemulsion formulation (MIC, IC90 and IC50) against - Fusarium sp. germination assay shows that the current ME formulation is non-phytotoxic to tomato seeds at all concentrations with germination % of 91-93%. Another embodiment of the present invention provides a bio-pesticide comprising 1394 ppm to 4000 ppm amount of the oil-in-water microemulsion formulation developed in the present invention.
Pot studies conducted using such a bio-pesticide exhibited the antifungal efficacy of about 55-70% against wilt inducing fungus F. oxysporum. Specifically, among the two different treatments (seedling and soil), soil treatment has been found to be most effective as it reduces 68.42 % wilt incidence at MIC followed by seedling treatment (59.17 % reduction).
Therefore, the micro-emulsion formulation of the present invention that essentially comprises two opposite nature ingredients in two different phases of the emulsion i.e. lipophilic bioactive components in the dispersed phase and hydrophilic bioactive component in the continuous phase is advantageously capable of delivering antifungal active ingredients from both dispersed and continuous phases. Thus the currently developed formulation is highly effective even after harsh storage conditions and shows antifungal activity under both in vitro and in vivo conditions. The present invention can be further described by way of non-limiting examples: EXAMPLES:
Example 1: Synergism of clove and lemongrass oil against F. oxysporum
Example 1 illustrates the quantitative effects of EOs used in the present microemulsion formulation comprising a mixture of clove oil and lemongrass oil in the dispersed phase, in terms of FIC (fractional inhibitory concentration) indices.
The FIC indices are calculated as FICA + FICB, where FICA and FICB are the minimum concentrations that inhibited the bacterial growth for EOs A (clove oil) and B (lemongrass oil), respectively. Thus, FICs are calculated as follows: FICA = (MIC combination / MICA alone) and FICB = (MICB combination / MICB alone). The results are interpreted as synergy (FIC < 0.5), addition (0.5 < FIC < 1), indifference (1 < FIC < 4) or antagonism (FIC > 4) (Schelz at el., 2006).
TABLE 1
SN Parameters MIC (ppm) FICA FICB FIC Index Remark
(FICA +
FICB)
1 Clove oil(A) 31.25 (MICA) - -
2 Lemon grass oil(B) 62.5 (MICB) - -
3 Clove - 3.90 (MICA/B) 0.125 0.25 0.375 Synergism
Lemongrass oil 15.625 (MICB/A)
Results: According to the data in table 1 above, the FICA + FICB value for the EOs used in the present formulation (clove oil and lemongrass oil) is found to be 0.375 (< 0.5), hence it is concluded that the two EOs are synergistic to each other in terms of antifungal activity.
Example 2: Preparation of oil-in water microemulsion containing EO mixture (1:1 ratio) in dispersed phase and mustard cake extract in continuous phase Example 2 illustrates the four different microemulsion compositions prepared in accordance with the present invention. These compositions are depicted in tables 2 to 7 below:
TABLE 2
Composition A
Component Weight %
Active ingredients in Clove + lemongrass oil 5
dispersed phase
Surfactant mixture (Smix) COE-40 14
Tween-20 6
Hydrophilic component Propylene glycol 0
water 75
Total 100
TABLE 3
Composition B
Component Weight %
Active ingredients in Clove + lemongrass oil 5
dispersed phase
Surfactant mixture (Smix) COE-40 10.5
Tween-20 4.5
Hydrophilic component Propylene glycol 5
water 75
Total 100 TABLE 4
Composition C
Component Weight %
Active ingredients in dispersed Clove + lemongrass oil 5 phase
Surfactant mixture (Smix) COE-40 10.5
Tween-20 4.5
Hydrophilic component Propylene glycol 5
water 56.25
Active in continuous phase Mustard cake extract 18.75
Total 100 TABLE 5
Composition D
Component Weight %
Active ingredients in dispersed Clove + lemongrass oil 5 phase
Surfactant mixture (Smix) COE-40 10.5
Tween-20 4.5
Hydrophilic component Propylene glycol 5
water 37.5
Active in continuous phase Mustard cake extract 37.5
Total 100 TABLE 6
Composition E
Component Weight %
Active ingredients in dispersed Clove + lemongrass oil 5 phase
Surfactant mixture (Smix) COE-40 10.5
Tween-20 4.5
Hydrophilic component Propylene glycol 5
water 18.75
Active in continuous phase Mustard cake extract 56.25
Total 100
TABLE 7
Composition F
Component Weight %
Active ingredients in dispersed Clove + lemongrass oil 5 phase
Surfactant mixture (Smix) COE-40 10.5
Tween-20 4.5
Hydrophilic component Propylene glycol 5
Water
Active in continuous phase Mustard cake extract 75
Total 100
All the above formulations are transparent or slightly opalescent microemulsions formed spontaneously upon mixing. After 15 days at 40°C & 70% RH, these samples of the microemulsions are visually inspected, and no indication of physical instability is found. Example 3: In vitro Bioefficacy of microemulsion compositions (B and D) against Fusarium oxysporum (Before and after accelerated storage stability test)
Example 3 demonstrates the enhanced antifungal efficacy of the present microemulsion formulation by virtue of the presence of hydrophilic mustard cake aqueous extract in the continuous phase.
Procedure: Microemulsions with different ratio of mustard cake extract are prepared and their MIC values against F. oxysporum are determined through poisoned food technique. PDA (Potato Dextrose Agar) (1000 ml) is poured into sterilized Petri dishes (90 mm diameter) and measured amount of microemulsion (for e.g. For 4000 ppm- 0.4g in 100 ml; and for 65000 ppm- 0.65 g in 100ml) is added to get the required concentrations.
The control sets are prepared using equal amounts of blank formulation (without active ingredients) in place of oil. A fungal disc (5 mm in diameter) of F. oxysporum, cut from the periphery of a five day-old culture using a cork borer, is inoculated aseptically into the centre of each Petri dish. The plates are sealed with polyethylene film and incubated at a temperature of 28+2°C until the growth in the control plates reaches the edge of the plates. The plates are used in triplicate for each treatment. Percentage inhibition of the radial growth by different oils compared to control is calculated using below equation:
% Inhibition = (C-T)/0100 where C is radial growth in control and T is radial growth in different concentrations of microemulsion.
Results: It is found that the microemulsions with mustard cake extract in continuous phase are more toxic and renders better pathogenicity (MIC: 4000 ppm) compared to compositions without the extract (MIC: 6000 ppm).
Storage Study: The critical role of mustard cake extract in continuous phase of the present formulation is further highlighted when two of the microemulsions developed i.e. Composition B (without mustard cake extract) and D (with 50% mustard cake extract) are kept at 40°C at 70% RH for 15 days for their stability tests. Results: After 15 days, no separation of phases (oil and water) occurs, which is suggestive of the shelf life of the formulation to be two years at room temperature. However, the antifungal efficacy of composition B and D before and after storage are found to be very significantly different to each other. Further, it is evident from the above results read along with accompanying figures 1-2 that the antifungal efficacy of composition D (Figure 1) does not get affected (94.5% inhibition at MIC value of 0 day), whereas, composition B comparatively deteriorated in terms of efficacy and only 83.5 % inhibition is observed at its MIC value i.e. 6000 ppm (Figure 2).
Further, logistic growth kinetics is used to determine the rate of killing fungal spores by microemulsions with following logistic equation: dyr/dt = - dyv/dt = kyv ( 1- yr/ym) (1)
and integrated form of Logistic equation is:
yr = ym/{ 1+ ((ym/y0)-l)eA-kt} , (2)
wherein, yv is the percentage of viable spores, yr represents the spore reduction (%), k is the growth rate constant of reduced spores, ym is the maximum possible spore reduction (%), y0 is the initial spore reduction (%), minimum inhibitory concentration (MIC), time needed for fungicidal effect (t), maximum possible percentage of reduced spores (ym), initial percentage of reduced spores (yo), growth rate constant of reduced spores (k) and coefficient of determination (R2). Results: The overall results obtained have been provided in table 8 below:
TABLE 8
MIC t (min) ym (%) y0 (%) k x 102 R2
(ppm) (min"1)
Composition 6000 90 98.9 ± 22.1 ± 1.73 6.17 0.98 B 1.28
Composition 4000 60 98.3 ± 28.3 ± 1.13 8.22 0.97 D 1.49 Further, Figure 3 demonstrates F. oxysporum spore reduction (%) during time by using minimum fungicidal concentrations of composition B and composition D (b). The kinetic models thus reveal 1.33 times faster fungicidal activity of composition D compared to composition B, thus justifying the significance of using active in continuous phase of the present microemulsion formulation.
Example 4: Preparation of a comparative oil-in water microemulsion containing a single EO in dispersed phase and mustard cake extract in continuous phase
Example 4 illustrates a comparative microemulsion wherein the continuous phase comprises of only one oil i.e. clove oil, as depicted in table 9 below:
TABLE 9
Composition G
Component Weight %
Active ingredients in dispersed Clove oil 2.5 phase
Surfactant mixture (Smix) COE-40 14
Tween-20 6
Hydrophilic component Propylene glycol 10.5
Water 38.5
Active in continuous phase Mustard cake extract 38.5
Total 100
The above formulation is transparent microemulsions formed spontaneously upon mixing. After 15 days at 40°C & 70% RH, this sample of the microemulsions is visually inspected, and no indication of physical instability is found.
Further, the antifungal efficacy / minimum inhibitory concentration (MIC) of composition G is found to be 6000 ppm. The MIC value thus obtained for composition G shows lesser efficacy than that of composition D (currently developed composition having MIC at 4000ppm), but is at par with composition B (without bioactive ingredient in continuous phase; MIC at 6000ppm). This loss of efficacy is attributed towards the presence of single/lower amount of EO in composition G which equates to the MIC of composition B that is devoid of any bioactive ingredient in continuous phase. Whereas, the higher efficacy of current composition D is due to the presence of both these essential features together i.e. a synergistic mixture of two EOs in dispersed phase along with presence of an aqueous extract of a hydrophilic bioactive ingredient in continuous phase.
Example 5: Effect of microemulsion (ME) formulation (composition D) on tomato seed germination and incidence of Fusarium wilt in tomato crops
Example 5 illustrates the Germination assay conducted on current ME formulation.
Procedure: Germination plastic tray are filled with soilless growth medium (cocopeat: vermiculite: perlite=3: l : l). Tomato seeds (variety PUSA Ruby) are sterilized by 4% sodium hypochlorite solution by keeping the seeds in the solution for 2 minutes and then washed with distilled water 3 times and are soaked in tissue paper. Treatment consists of selected microemulsion (composition D) formulation with different concentrations (MIC, MIC90 and MIC50). Seeds are then dipped in different treatments for 30 min. 2 types of control are taken, positive control (without F. oxysporum, healthy soil) and negative control (with F. oxysporum, unhealthy soil). Experiment is conducted for 8 days and repeated thrice. Seedling Vigor is the sum total of those properties of the seed which determine the level of activity and performance of the seed or seed lot during germination and seedling emergence. It is measured by two formulas given below:
SVIL= Germination % χ Seedling Length (cm)
SVIw= Germination % χ Seedling Weight (g)
Results: The data reveals that the present microemulsion formulation treatments do not affect the germination of tomato seeds even in the presence of wilt fungus and thus produce a healthy seedling indicated by high seedling vigour index as provided in table 10 below:
TABLE 10
S.no Concentration Germinatio Seedling Dry SVIL SVIw
(ppm) n length Seedling
percentage (cm) Weight
(%) (g)
1 MIC50 92.3 18.23±1.10 9.10±0.52 1682.62 839.93
2 MIC 91.9 28.06±1.89 21.66±0.83 2578.71 1990.55
3 MIC90 91.6 28.73±1.80 21.80±0.69 2631.66 1996.88 4 Positive control 93.2 30.36±0.55 22.10±0.10 2829.55 2059.72
5 Negative control 84 .5 17.43±0.86 7.33±0.15 1533.84 645.04
Wilt Incidence Study:
For wilt incidence study, seeds, seedlings and soil are treated with above mentioned three concentrations of microemulsion formulation. In brief, soil is autoclaved and artificially inoculated with Fusarium spores (@ 2.6 x 105 spores/g soil). Seeds are treated with microemulsion formulations by the method used for germination study, but herein, seeds are sowed directly into 1 kg diseased pot. For seedling treatment, healthy eight-leaf staged seedlings of tomato are treated with three respective concentrations of microemulsion while in case of soil treatment; soil of pot is treated @ 5 ml per 150 cc soil. Healthy and untreated seedlings are taken as control. Each treatment has 5 replicates and all the pots are kept in the net house in Micro model, IITD for 45 days. Carbendazim (@0.1%) is taken as chemical control. For accessing the disease progression in the tomato plant, following grading system is used. Symptoms like yellowing of leaves, wilting of plant, height and weight of plant are examined and given a grade by comparing with the control having maximum diseases infection.
Disease progresses in microemulsion treated tomato plants are compared to those in the untreated plants, and demonstrated in terms of Area Under Disease Progression curve (AUDPC). Area under the disease progress curve (AUDPC) is a method to calculate the percentage inhibition of wilt disease and is calculated as:
AUDPC =∑ [(Ri+1 + Ri)/2][ti+l - ti],
R = disease rating at the ith observation
ti= time (days) since previous ratings at the ith observation,
n = total number of observations.
Results: Relative AUDPC (%) is obtained for pesticide-treated plant by comparison with the AUDPC data of the non-treated plant as 100% (as demonstrated graphically by figure 4). The best protection in autumn season is observed in soil treatment by microemulsion at MIC dose (68.42 %) followed by seedling treatment (59.17 %). The data has been depicted in table 11 below: TABLE 11
Treatment Disease reduction % of FoL
Micro emulsion @ Chemical (carbendazim)
@ 0.1%
IC 50 IC 90 MIC
Seedling 24.73 57.39 59.17 60.02
Soil 31.45 65.26 68.42 71.24

Claims

1. An antifungal oil-in-water microemulsion formulation comprising:
a) 2.5-5 wt.% of a mixture of lipophilic bioactive ingredients in dispersed phase; b) 18-57 wt.% of a plant biomass aqueous extract in continuous phase of distilled water; and
c) 5-20 wt.% of an amphiphilic surfactant.
2. The microemulsion formulation as claimed in claim 1, wherein the lipophilic bioactive ingredient is selected from a group of essential oils consisting of clove oil, lemon grass oil, mint oil, thyme oil, eucalyptus oil, ginger oil, sesame oil, basil oil, geranium oil, rosemary oil, lavender oil, marigold oil and combinations thereof.
3. The microemulsion formulation as claimed in claim 1, wherein the mixture of lipophilic bioactive ingredients preferably comprises two essential oils in a concentration ratio of 1 : 1.
4. The microemulsion formulation as claimed in claim 3, wherein the essential oils are clove oil and lemongrass oil.
5. The microemulsion formulation as claimed in claim 4 having an antifungal activity (FIC Index) of 0.25-0.375.
6. The microemulsion formulation as claimed in claim 1, wherein the plant biomass aqueous extract in continuous phase is selected from edible oil cakes, non-edible oil cakes or herbs.
7. The microemulsion formulation as claimed in claim 6, wherein edible oil cakes are selected from mustard cake, cotton seed cake, groundnut cake, sesame cake, linseed cake, coconut cake, olive cake, sunflower oil cake or palm oil cake.
8. The microemulsion formulation as claimed in claim 6, wherein non-edible oil cakes are selected from jatropha cake, neem cake, castor cake, karanja cake, simorubha cake or tung cake.
9. The microemulsion formulation as claimed in claim 6 wherein herbs are selected from Allium sativum. Piper nigrum. Zingiber officinale. Piper longum, Ocimum sanctum, Curcuma longa, Cinnamomum zeylanicum, or Piper longum.
10. The microemulsion formulation as claimed in claim 7, wherein the edible oil cake is preferably mustard cake aqueous extract.
11. The microemulsion formulation as claimed in claim 10, wherein the mustard cake aqueous extract is present in an amount of 25-75 wt.% of continuous phase.
12. The microemulsion formulation as claimed in claim 1, wherein the amphiphilic surfactant is selected from a group consisting of phospholipids, alkyl polyglucosides, sorbitan fatty esters, polyalkyleneglycol ethers of fatty alcohols, pegylated monoester of fatty acid glycerols, pegylated diesters of fatty acid glycerols, and combinations thereof.
13. The microemulsion formulation as claimed in claim 12, wherein the amphiphilic surfactant is preferably a combination of castor oil ethoxylates 40 moles ethylene oxides and polyoxyethylene sorbitan monolaurate.
14. The microemulsion formulation as claimed in claim 13, wherein the castor oil ethoxylates 40 moles ethylene oxides and polyoxyethylene sorbitan monolaurate are present in a ratio selected from 1 : 1, 6.4, 7:3 or 8:2.
15. An antifungal oil-in-water microemulsion formulation comprising a) 2.5-5 wt.% of a mixture clove oil and lemongrass oil at a ratio of 1 : 1 in dispersed phase; b) 18-57 wt.% of a mustard cake aqueous extract in continuous phase of distilled water; and c) 5-20 wt.% of castor oil ethoxylates 40 moles ethylene oxides and polyoxyethyene sorbitan monolaurate at ratio selected from 1 : 1, 6.4, 7:3 or 8:2.
16. The microemulsion formulation as claimed in claims 1 and 15, wherein the formulation has a shelf life of two years at room temperature.
17. The microemulsion formulation as claimed in claims 1 and 15 having 1.33-7 times faster fungicidal activity against wilt inducing fungus F. oxysporum
18. The microemulsion formulation as claimed in claims 1 and 15 having a minimum inhibitory concentration (MIC) value at 4000 ppm against wilt inducing fungus F. oxysporum.
19. The microemulsion formulation as claimed in claims 1 and 15 having a germination % of tomato seeds ranging between 91-93%.
20. The microemulsion formulation as claimed in claims 1 and 15 has a particle size of 20- 100 nm.
21. The microemulsion formulation as claimed in claims 1 and 15 is non-phytotoxic.
22. A fungicidal composition comprising 1394 ppm to 4000 ppm amount of the oil-in- water microemulsion formulation as claimed in any preceding claims.
23. The fungicidal composition as claimed in claim 22 provides an antifungal efficacy of 55-70 % against wilt inducing fungus F. oxysporum.
PCT/IB2018/056823 2017-09-07 2018-09-07 A novel green micro-emulsion for controlling fungal wilt diseases WO2019049072A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP18854764.0A EP3678641A4 (en) 2017-09-07 2018-09-07 A novel green micro-emulsion for controlling fungal wilt diseases
BR112020004685-0A BR112020004685A2 (en) 2017-09-07 2018-09-07 formulation of antifungal microemulsion oil in water and fungicidal composition
US16/645,529 US20200281194A1 (en) 2017-09-07 2018-09-07 A Novel Green Micro-Emulsion for Controlling Fungal Wilt Diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201711031634 2017-09-07
IN201711031634 2017-09-07

Publications (1)

Publication Number Publication Date
WO2019049072A1 true WO2019049072A1 (en) 2019-03-14

Family

ID=65634895

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2018/056823 WO2019049072A1 (en) 2017-09-07 2018-09-07 A novel green micro-emulsion for controlling fungal wilt diseases

Country Status (4)

Country Link
US (1) US20200281194A1 (en)
EP (1) EP3678641A4 (en)
BR (1) BR112020004685A2 (en)
WO (1) WO2019049072A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110833076A (en) * 2019-11-22 2020-02-25 贵州省油料研究所 Rosemary essential oil microemulsion for preventing and treating plant diseases and insect pests and preparation method thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116076491A (en) * 2022-12-12 2023-05-09 云南中医药大学 Preparation method of enhanced lemon grass volatile oil antibacterial active agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176603A (en) * 2016-08-15 2016-12-07 湖南仁馨生物技术有限公司 A kind of plants essential oil micro emulsion gel and its preparation method and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687002B2 (en) * 2015-05-21 2017-06-27 IndusCo, Ltd. Botanical antimicrobial microemulsions (BAMM)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106176603A (en) * 2016-08-15 2016-12-07 湖南仁馨生物技术有限公司 A kind of plants essential oil micro emulsion gel and its preparation method and application

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KALEMBA DA: "Antibacterial and antifungal properties of essential oils", CURRENT MEDICINAL CHEMISTRY, vol. 10, no. 10, 1 May 2003 (2003-05-01), pages 813 - 29, XP008056360, DOI: doi:10.2174/0929867033457719 *
MA Q ET AL.: "Antimicrobial properties of microemulsions formulated with essential oils, soybean oil, and Tween 80", INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, vol. 226, 2 June 2016 (2016-06-02), pages 20 - 5, XP029496211, DOI: doi:10.1016/j.ijfoodmicro.2016.03.011 *
PAWAR VC ET AL.: "Thaker VS. Evaluation of the anti-Fusarium oxysporum f. sp cicer and anti-Alternaria porri effects of some essential oils", WORLD JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, vol. 23, no. 8, 1 August 2007 (2007-08-01), pages 1099 - 106, XP019535127, DOI: doi:10.1007/s11274-006-9339-6 *
See also references of EP3678641A4 *
SHARMA A ET AL.: "Antifungal activities of selected essential oils against Fusarium oxysporum f. sp. lycopersici 1322, with emphasis on Syzygium aromaticum essential oil", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, vol. 123, no. 3, 1 March 2017 (2017-03-01), pages 308 - 13, XP029924061 *
TRADITIONAL KNOWLEDGE DATABASE: ENTRY NUMBER: ''PD/364R1'' ''GHORACOLI-YOGA'' KNOWLEDGE SINCE: 100 YEARS INGREDIENTS, USE *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110833076A (en) * 2019-11-22 2020-02-25 贵州省油料研究所 Rosemary essential oil microemulsion for preventing and treating plant diseases and insect pests and preparation method thereof

Also Published As

Publication number Publication date
EP3678641A1 (en) 2020-07-15
EP3678641A4 (en) 2021-05-26
US20200281194A1 (en) 2020-09-10
BR112020004685A2 (en) 2020-09-15

Similar Documents

Publication Publication Date Title
Amadioha Controlling rice blast in vitro and in vivo with extracts of Azadirachta indica
US20070237837A1 (en) Biocompatible tea tree oil compositions
JP2022524676A (en) Antibacterial nanoemulsion
CN102805115B (en) Plant-source natural fungicide for preventing and controlling botrytis cinerea and preparation method thereof
JP5514829B2 (en) Cinnamaldehyde-allysine compositions and uses thereof
Cespedes et al. New environmentally-friendly antimicrobials and biocides from Andean and Mexican biodiversity
KR101270628B1 (en) The composition comprising extraction or fraction of Phellodendron amurense having insect resistance or insecticidal activities for protection of cultural heritage
CN103444759B (en) Isorhodanate and matrine mixture and its application
KR20190052979A (en) Organic agricultural material composition for pest management by using 4 kinds of plant extracts
JP5637737B2 (en) Spray for controlling fly flies
Gupta Efficacy of neem in combination with cow urine against mustard aphid and its effect on coccinellid predators
WO2009093079A2 (en) Environmentally friendly plant protection agents
US20200281194A1 (en) A Novel Green Micro-Emulsion for Controlling Fungal Wilt Diseases
US20050084545A1 (en) Non phytotoxic biocide composition containing tea tree oil and method of production the same
WO2019164344A1 (en) Temperature stable composition for controlling pests and method for controlling pests using same
KR101464335B1 (en) Composition for controlling plant diseases containing plant extracts
KR20190052978A (en) Organic agricultural material composition for pest management by using 3kinds of plant extracts
US20150072030A1 (en) Biocompatible tea tree oil compositions
WO2018058393A1 (en) Insecticide and preparation method thereof
ES2924416T3 (en) An ecological disinfectant composition for agricultural soils comprising a mixture of Capsicum extract, calendula extract and garlic extract
JP4836763B2 (en) Thrips control agent
KR102592216B1 (en) Composition for controlling gypsy moth egg mass
Yapa et al. Next-Generation Bionanofungicides Against Agricultural Pathogens
CN111295095A (en) Composition containing geraniol for controlling plant parasitic nematodes
JP2005075753A (en) Noxious insect-controlling agent for plant

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18854764

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112020004685

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 2018854764

Country of ref document: EP

Effective date: 20200407

ENP Entry into the national phase

Ref document number: 112020004685

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20200309